Cable Hill Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$663K Buy
6,441
+232
+4% +$23.4K 0.06% 68
2024
Q4
$555K Buy
6,209
+323
+5% +$28.4K 0.06% 82
2024
Q3
$493K Sell
5,886
-159
-3% -$12.5K 0.05% 90
2024
Q2
$466K Buy
+6,045
New +$442K 0.05% 94
2023
Q4
Sell
-6,411
Closed -$338K 119
2023
Q3
$338K Sell
6,411
-201
-3% -$10.5K 0.05% 109
2023
Q2
$358K Sell
6,612
-311
-4% -$16.2K 0.05% 110
2023
Q1
$346K Sell
6,923
-514
-7% -$24.2K 0.06% 118
2022
Q4
$344K Buy
+7,437
New +$322K 0.06% 115
2019
Q2
Sell
-817
Closed -$31K 196
2019
Q1
$31K Sell
817
-98
-11% -$3.74K 0.01% 309
2018
Q4
$32K Hold
915
0.01% 295
2018
Q3
$35K Sell
915
-125
-12% -$4.37K 0.01% 229
2018
Q2
$34K Hold
1,040
0.01% 247
2018
Q1
$28K Buy
1,040
+188
+22% +$5.11K 0.01% 279
2017
Q4
$22K Sell
852
-87
-9% -$2.4K 0.01% 370
2017
Q3
$27K Buy
+939
New +$25.9K 0.01% 344

Other funds holding BSX

Cable Hill Partners's BSX Position: Q1 2025 in Review

Cable Hill Partners increased its Boston Scientific (BSX) stake by 3.7% in Q1 2025, buying an estimated $23.4K and bringing the position to 6,441 shares worth $663K. The position accounts for 0.06% of the portfolio, ranked #68.

Cable Hill Partners first reported a position in BSX in Q3 2017 and has held it in 15 quarters since. 1,644 funds tracked by Wall St. Rank hold BSX as of Q1 2025.

  • Cable Hill Partners held 6,441 shares of Boston Scientific worth $663K as of Q1 2025.
  • Cable Hill Partners bought 232 Boston Scientific shares in Q1 2025, an estimated $23.4K.
  • Boston Scientific made up 0.06% of Cable Hill Partners's portfolio in Q1 2025, its #68 holding.
  • Cable Hill Partners first reported a position in Boston Scientific in Q3 2017 and has held it in 15 quarters since.
  • 1,644 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.

Based on Cable Hill Partners's 13F filing for Q1 2025, filed 2 May 2025.